DISEASE INDICATIONS: Achondroplasia
MANUFACTURER: BioMarin Europe Ltd
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Voxzogo is a synthetic copy of C-type natriuretic peptide that is used to treat achondroplasia, a genetic disorder causing short stature and limb abnormalities.